NIH-funded research R01 grant

Investigating treatments for single ventricle heart disease

Official title: Targeting Mitochondria in Single Ventricle Heart Disease

Funded at University of Colorado Denver · NIH-11004040 · Data updated 2026-11-12

This study is looking at the special challenges young adults with single ventricle congenital heart disease face as they grow up, and it aims to find better treatments for heart failure that are specific to their needs.

More Heart Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMarch 15, 2021
Project endJanuary 31, 2026
Funding year2025
Award (this year)$585,849
NIH project number5R01HL156670-05
Project IDNIH-11004040 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with single ventricle congenital heart disease, particularly those transitioning into adulthood.

Less likely to help

Patients with other types of congenital heart disease or those without a diagnosis of single ventricle heart disease may not benefit from this research.

What this research studies

This research focuses on understanding the unique challenges faced by patients with single ventricle congenital heart disease as they transition into adulthood. It aims to explore the mechanisms of heart failure specific to this condition, which is often overlooked in traditional heart failure studies. By examining the effects of existing therapies, such as phosphodiesterase-5 inhibitors, the research seeks to identify more effective targeted treatments for these patients. The study will utilize a combination of clinical data and biological samples to better understand the disease and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to more effective and tailored treatments for patients with single ventricle heart disease, improving their quality of life and longevity.

How similar studies have gone: While there is limited research specifically targeting single ventricle heart disease, similar approaches in other heart conditions have shown promise, indicating potential for success in this area.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Miyamoto, Shelley Deanne — University of Colorado Denver
  • Study coordinator: Miyamoto, Shelley Deanne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.